TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT
6.1. Overview
6.2. Low Molecular Weight Heparin
6.3. Unfractionated Heparin
7. GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE
7.1. Overview
7.2. Porcine
7.3. Bovine
8. GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION
8.1. Overview
8.2. Venous Thromboembolism
8.3. Atrial Fibrillation/Flutter
8.4. Coronary Artery Disease
8.5. Other Applications
9. GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL
9.1. Overview
9.2. Hospital Pharmacy
9.3. Retail Pharmacy
9.4. Online Pharmacy
10. GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Lab-synthesized Heparin Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Lab-synthesized Heparin Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure, 2023
12. COMPANY PROFILES
12.1. Fresenius Kabi
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Techdow USA
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. B. Bruan
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. AMPHASTAR
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Leo Pharma
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Sanofi
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Pfizer
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Shenzhen Hepalink
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Changzhou Qianhong Biopharma
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Yantai Dongcheng Biochemicals Co., Ltd.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 11 US: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 US: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 13 US: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 US: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 15 CANADA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 CANADA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 17 CANADA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 CANADA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 4 EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 7 GERMANY: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 GERMANY: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 FRANCE: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 11 FRANCE: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 FRANCE: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 13 ITALY: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 ITALY: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 15 ITALY: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 16 ITALY: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 17 SPAIN: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 SPAIN: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 19 SPAIN: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 20 SPAIN: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 21 UK: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 UK: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 23 UK: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 UK: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 33 JAPAN: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 JAPAN: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 35 JAPAN: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 JAPAN: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 37 CHINA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 38 CHINA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 39 CHINA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 40 CHINA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 41 INDIA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 42 INDIA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 43 INDIA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 44 INDIA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 45 AUSTRALIA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 46 AUSTRALIA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 47 AUSTRALIA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 66 AFRICA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 67 AFRICA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 68 AFRICA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY SOURCE, 2019-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL LAB-SYNTHESIZED HEPARIN MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL LAB-SYNTHESIZED HEPARIN MARKET
FIGURE 4 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), PRODUCT, 2023
FIGURE 5 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY SOURCE, 2023
FIGURE 6 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2023
FIGURE 8 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: LAB-SYNTHESIZED HEPARIN MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL LAB-SYNTHESIZED HEPARIN MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 FRESENIUS KABI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 FRESENIUS KABI: SWOT ANALYSIS
FIGURE 16 TECHDOW USA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 TECHDOW USA: SWOT ANALYSIS
FIGURE 18 B. BRUAN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 B. BRUAN: SWOT ANALYSIS
FIGURE 20 AMPHASTAR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 AMPHASTAR: SWOT ANALYSIS
FIGURE 22 LEO PHARMA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 LEO PHARMA.: SWOT ANALYSIS
FIGURE 24 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 SANOFI: SWOT ANALYSIS
FIGURE 26 PFIZER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PFIZER: SWOT ANALYSIS
FIGURE 28 SHENZHEN HEPALINK: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 SHENZHEN HEPALINK: SWOT ANALYSIS
FIGURE 30 CHANGZHOU QIANHONG BIOPHARMA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 CHANGZHOU QIANHONG BIOPHARMA: SWOT ANALYSIS
FIGURE 32 YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: SWOT ANALYSIS
